Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia

Progress in Neuro-psychopharmacology & Biological Psychiatry
Puay San WoonKang Sim

Abstract

Quality of life (QOL) impairment is evident in patients with schizophrenia and is increasingly recognised as an important evaluation criterion of treatment outcome. Hence, this study aimed to identify the neurocognitive, clinical and functional parameters associated with subjective QOL in patients with schizophrenia within an Asian context, and specifically in an outpatient setting. This study was conducted on 83 outpatients with DSM-IV diagnosis of schizophrenia, and 47 age- and gender-matched healthy controls. All participants were administered with the World Health Organisation Quality of Life Assessment-Brief Form (WHOQOL-BREF) and Brief Assessment of Cognition in Schizophrenia (BACS), to measure quality of life and cognitive function respectively. Patients were also assessed for severity of psychopathology, as well as level of psychosocial functioning, using the Positive and Negative Syndrome Scale (PANSS) and Global Assessment of Functioning (GAF) rating scales respectively. Specific psychopathology (greater severity of PANSS negative symptoms, general psychopathology subscale scores), cognitive deficits (working and verbal memories), and lower GAF scores were correlated with poorer QOL in patients. Multivariate analyses ...Continue Reading

References

Jun 1, 1978·The Journal of Nervous and Mental Disease·R K HeatonR A Lehman
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Mar 1, 1996·The American Journal of Psychiatry·M F Green
Mar 1, 1997·Comprehensive Psychiatry·Y KimH Miyaoka
May 3, 1997·Schizophrenia Research·D I VelliganA L Miller
Feb 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·S BrowneE O'Callaghan
Sep 19, 2000·Schizophrenia Bulletin·A G Awad, L N Voruganti
May 31, 2001·Acta Psychiatrica Scandinavica·P B FitzgeraldJ Kulkarni
Aug 16, 2001·The Journal of Nervous and Mental Disease·P H LysakerK A Marks
Aug 24, 2001·Schizophrenia Research·J D HuppertT E Smith
Jan 5, 2002·Social Psychiatry and Psychiatric Epidemiology·R K SalokangasA M Koivisto
Oct 24, 2002·Social Psychiatry and Psychiatric Epidemiology·Helen HerrmanRosemary Thomas
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gökay AksarayCengiz Bal
Nov 5, 2004·International Journal of Geriatric Psychiatry·Silvia Rodriguez-FerreraSayeed Haque
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Köksal AlptekinArzu Kitiş
Aug 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Mirella RuggeriMichele Tansella
Sep 21, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Alex HoferW Wolfgang Fleischhacker
Nov 29, 2005·European Archives of Psychiatry and Clinical Neuroscience·Alex HoferW Wolfgang Fleischhacker
Jun 14, 2006·Comprehensive Psychiatry·Ilanit Hasson-OhayonMark Weiser
Aug 12, 2006·European Archives of Psychiatry and Clinical Neuroscience·Stanley H MutsatsaThomas R E Barnes
Sep 8, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Frederick Ka Ching Yeung, Sunny Ho Wan Chan
Jan 6, 2007·Schizophrenia Bulletin·Shaun M Eack, Christina E Newhill
Apr 4, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Michael S Ritsner
Sep 14, 2007·Schizophrenia Research·Deborah A PerlickJoseph Collins
Oct 9, 2007·Schizophrenia Research·Jenille M NarvaezThomas L Patterson
May 10, 2008·The Australian and New Zealand Journal of Psychiatry·Kara SavillaCherrie Galletly
Jan 27, 2009·Schizophrenia Research·David P FolsomDilip V Jeste

❮ Previous
Next ❯

Citations

Feb 4, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Laia Mas-ExpósitoUNKNOWN Research Group on Severe Mental Disorder
Oct 17, 2012·Psychiatry and Clinical Neurosciences·Tsunehiko TanakaTetsuro Ohmori
Jan 1, 2010·Industrial Psychiatry Journal·Nishi Suchita KujurA N Verma
Nov 30, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rei KitajimaNoboru Yamaguchi
Sep 9, 2010·Journal of Psychiatric Research·Sanjaya SaxenaAlexander Bystritsky
Jan 27, 2012·Human Psychopharmacology·Tomomi TenjinNoboru Yamaguchi
Oct 10, 2013·Psychiatry and Clinical Neurosciences·Shin OginoNoboru Yamaguchi
Sep 11, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Shin OginoNoboru Yamaguchi
Nov 7, 2015·PloS One·Teruhisa UwatokoHidehiko Takahashi
May 24, 2019·The Psychiatric Quarterly·Min DongYu-Tao Xiang
Sep 24, 2020·Psychological Medicine·Mickael EhrmingerEric Brunet-Gouet
Oct 14, 2011·Psychiatry Investigation·Yun Young SongJun Soo Kwon
Oct 3, 2018·Epidemiology and Psychiatric Sciences·A G Nevarez-FloresA L Neil
May 28, 2021·NPJ Schizophrenia·Eric Brunet-GouetPaul Roux

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Psychiatric Services : a Journal of the American Psychiatric Association
Miranda H ChakosRobert A Rosenheck
Schizophrenia Research
Graham ThornicroftEPSILON Study Group
Progress in Neuro-psychopharmacology & Biological Psychiatry
Gökay AksarayCengiz Bal
© 2021 Meta ULC. All rights reserved